This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

High-end Cellomics Market

Market Insights on High-end Cellomics covering sales outlook, demand forecast & up-to-date key trends

High-end Cellomics Market by Application (Academic Research/Basic Research, Drug Discovery (Primary & Secondary Screening, Target Identification & Validation, Invitro Toxicity Studies, Compound Profiling), End User & Region, Forecast 2021 - 2031

High-end Cellomics Market Snapshot

[216 Pages Report] The High-end Cellomics Market revenue totaled US$ 288.8 Mn in 2021, according to Future Market Insights (FMI) study. The overall sales of high-end cellomics are expected to reach US$ 536.9 Mn by 2031, at a CAGR of 6.4% for 2021 - 2031.

High-end Cellomics allows analyzing how compound interacts with the target at the subcellular level, which delivers insights that can drive go/no-go decisions. Recent developments in drug discovery and high-end cellomics have augmented pressure at the strategic points along the drug discovery pipeline.

Thus, the rising need to determine and study toxicity levels in the initial phase of drug discovery is driving the market growth. The demand for drug discovery also will grow, accounting for nearly 55% of high-end Cellomics revenue in 2021. As per FMI, the high-end Cellomics market represented 1% to 2% of overall sales in US$ 21.09 Bn worth high throughput screening market in 2020.

Market Outlook:

Data Points

Market Insights

High-end Cellomics Market Value 2020

US$ 273.9Mn

Estimated High-end Cellomics Market Value 2021

US$ 288.8Mn

CAGR 2021-2031

6.4%

Key Players

PerkinElmer Inc., Molecular Devices LLC (Danaher Corporation LLC), Thermofisher Scientific and Yokagawa Electric Corporatoin

Customize this Report

Let us know your requirement to get
100% FREE customization

2016-2020 High-end Cellomics Demand Outlook Compared to 2021-2031 Forecast

According to Future Market Insights (FMI), the sales of high-end cellomics have grown at a CAGR of 6.4% during 2021- 2031. Due to the rising prevalence of several genetic disorders and neurological diseases, the demand for effective screening methods and techniques has increased in the last decade. This had a positive impact on the high-end cellomics market.

Initiatives undertaken by governments to promote advanced research in biotechnology will increase installation of high-end cellomics instruments for drug discovery applications. Cities of India such as Bangalore, Pune, Hyderabad, and Tamil Nadu have well-established biotechnology research infrastructure recognized globally, which will drive the demand for high-end research instruments. 

Apart from India, China, and the U.S., governments of Japan, Brazil, the U.K., and Australia are supporting their domestic biotechnology and bioscience industry through similar initiatives. Factors such as these are expected to create lucrative growth opportunities for manufacturers operating in the global high-end cellomics market

High-end Cellomics Market Download Report Brochure

How will Development of Advanced Imaging Systems Augment High-end Cellomics Market Growth?

High-end cellomics has recently acquired substantial traction due to its capacity to investigate features across numerous parts of cell biology and drug discovery and development process. Because of their increased application in life sciences research, these systems have seen technological breakthroughs in automated microscope hardware, sCMOS cameras, confocal optics, oil immersion objective lenses, and throughput capabilities.

Furthermore, these systems have increased software data analysis and data management capabilities. Considering these advancements, the industry players are focusing on introducing new products with these features. Some of the recent launches in this regard include:

In January 2021, Molecular Devices LLC introduced a new high content screening system – ImageXpress Confocal HT.ai High Content HT.ai. This device enables researchers to accelerate their study on phenotypic screening of organoid models. Quick Image acquisition and multiplexing flexibility with high performing lasers are some of the benefits offered by this next-generation high content screening system.

Molecular Devices LLC, in December 2020, introduce water imaging technology for the ImageXpress Micro Confocal High-Content Imaging System. This latest system is developed on existing 3D imaging technology which enables acquisition and analysis of both 3D cell model assays such as spheroids, organoids, and organ-on-chip biology

Availability of such innovative products with associated benefits will lead to an increase adoption, thus fueling the growth of the global high-end cellomics market.

What are the Key Opportunities for High-end Cellomics Market Players?

High-end cellomics systems are used across a wide range of applications in drug discovery including primary and secondary screening, target identification and validation, toxicity testing, and compound profiling.

For pharmaceutical and biotechnology companies, which is one of the major end-users of these systems, having high-end high content screening equipment increases the total R&D cost of drug development. Also, budgetary constraints among the academic and research institutes lowers the adoption rate of the high-end cellomics systems.

These end-users prefer to outsource HCS services to independent contract research organizations (CROs), due to which the number of CROs offering these services is rising. Charles River Laboratories, Eurofins international are some of the CROs offering high-end cellomics services. Thus, the growing interest in outsourcing services is anticipated to positively drive the sales of the high-end cellomics systems, which in turn provides a lucrative opportunity for market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Will the High Cost of High-end Cellomics Instruments Lower their Adoption?

A high-end cellomics instrument is a set of various analytical methods including automated microscopy, image processing, and visualization tools in one single system. Also, these systems have improved features such as high throughput capacity, confocal optics, sCMOS cameras, water, and oil immersion lens. Hence they are priced on the higher-end.

Apart from the instrumentation cost, installation, maintenance and services costs also add up to the total cost of ownership, thus leading to an increase in the total spending. Academic research institutes, CROS, pharmaceutical and biotechnology companies who are the primary end-users of these systems, are sometimes reluctant for adoption owing to budgetary constraints.

This has made them shift towards other cell imaging analysis equipment such as cell imaging instruments and flow cytometry. This trend is particularly seen in the price-sensitive markets such as India. Thus, the high cost of these instruments coupled with the availability of alternative instruments is expected to create a negative impact on the market growth.

What is the Impact of the COVID-19 Crisis on the Market?

With this unprecedented crisis, the healthcare industry has found itself on the frontline to deal with the medical emergency which has not only ruined the economies across the globe but has also put huge pressure on the healthcare facilities.

The unexpected level of request for the testing kits has pushed the industry players into unexplored regions where their assets are confronted on regular basis. In addition to this, the supplies and demands were jolted by the massive infection spread, which staggered the supplies for manufacturing the high-end cellomics market.

As high-end cellomics instruments are used only for research purposes, the temporary halt in research and development activities has created a sharp reduction in demand for these products. Thus, the high-end cellomics market is expected to witness a short-term negative impact on market growth.

With the lifting of lockdown, reopening of the companies and industries, resuming research and development activities in cell-based research and drug discovery, government initiatives and reviewed market approaches, the high-end cellomics market will register increasing growth 2021 onwards.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Remain a Key High-end Cellomics Market?

In 2021, the U.S. high-end cellomics market will account for over 86% value share in North America. Demand in the U.S. is primarily driven by a strong regional economy, the presence of refined research and healthcare facilities, and improved attention on overall health and wellbeing.

How will Germany High-end Cellomics Market Fare?

Germany is expected to account for over 21% of the Europe market in 2031. Growing capital and venture investments for cellular research, technological developments in high-end cellomics solutions, cost restraint in pharma R&D, and the presence of key players have led resulted in high growth of the Germany market.

What are the Factors Supporting High-end Cellomics Sales in Australia?

The Australia market will exhibit a 5.0% CAGR throughout the forecast period. The rising prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s is one of the key factors driving the market growth. Similarly, the growing geriatric population is supplementing market growth in Australia.

What will Drive Demand in India High-end Cellomics Market?

The India market account for more than 67% of the sales registered in the South Asia region in 2021. Research activities in the biotechnology and bioscience field are increasing rapidly due to government support and the availability of funds, thus increasing the demand for high-end cellomics in India.

The Government of India is offering 100% foreign direct investment for biotechnology companies that are based outside India, and the GOI is offering public-private partnerships for the companies based in India. Also, the Department of Biotechnology has supported the biotechnology research infrastructure including high-end high content screening system, flow cytometry, imaging microarray, and high-resolution mass spectrometry facilities in Delhi and Mumbai respectively.

What is the Scope for Sales of High-end Cellomics in China?

The market for high-end cellomics in China is exhibiting 7.1% CAGR and is expected to account for 82% of the East Asia market in 2031. Government initiatives to spur biotechnology industry in the region is creating growth opportunities in China. China has included the biotechnology industry as one of the strategic priorities for development in terms of technology. Also, there were about 95 biotech-related deals till June 2020, drawing about USD 12 billion of deals. In 2020, Everest Medicines Ltd and Maxwell Biosciences Co. Ltd. raised USD 310 million in June and USD 279 million respectively. These companies have strong oncology and immunology products in their pipelines, which will require advanced instrumentation such as high-end HCS systems in the drug discovery phase for screening and compound profiling.

Category-wise Insights

What are the Sales Prospects in Drug Discovery?

High-end cellomics demand in drug discovery will consistently rise, registering a high share of 55% in 2021. Increasing support for research and development activities, particularly for rare diseases, and the growing use of informatics in drug discovery led to demand for Drug Discovery.

Why is Demand for High-end Cellomics High in Pharmaceutical & Biotechnology Companies?

Pharmaceutical & biotechnology companies are currently leading the market. Demand in the pharmaceutical & biotechnology companies is expected to grow by 6.2% CAGR. Pharmaceutical & biotechnology companies are using this informatics software widely for pre-clinical research & development, compound screening and lead documentation, target identification, and rationalization of their drug discovery process which is the key factor for propelling the growth of the Pharmaceutical & Biotechnology Companies segment. 

Competitive Landscape

Leading players are primarily focusing on market consolidation activities such as mergers, acquisitions, supply distribution partnerships, and launching new products, leading to high competitiveness in this space.

To capitalize on the growing market opportunity, market players are actively focusing on developing high-end cellomics instruments. These systems have increased software data analysis and data management capabilities. Quick image acquisition and multiplexing flexibility with high performing lasers and improved incubation environment are some of the benefits offered by these systems.

ImageXpress Confocal HT.ai High Content HT.ai.  (Molecular Devices LLC), ImageXpress Micro Confocal High-Content Imaging System (with water imaging technology)(Molecular Devices LLC), Cell Voyager CV8000 (Yokogawa) are some of the recent launches by the industry players in the global high-end cellomics market.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Application,  End-User, and Region

Key Companies Profiled

  • PerkinElmer, Inc.
  • ThermoFisher Scientific, Inc.
  • Molecular Devices LLC (part of Danaher Corporation) 
  • Yokogawa Electric Corporation

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

High-end Cellomics Market by Category

Application:

  • Academic Research/Basic Research
  • Drug Discovery
    • Primary & Secondary Screening
    • Target Identification & Validation
    • Invitro Toxicity Studies
    • Compound Profiling

End-User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Independent Contract Research Organizations (CROs)

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The high-end cellomics market will reach US$ 288.8 Mn in the year 2021 and is expected to surpass US$ 536.9 Mn by 2031.

High-end cellomics market is projected to register a CAGR of 6.4% during 2021-2031.

Growing Investments in cell-based research activities, development of advanced imaging systems, increasing applications in cellular disease modelling systems and growing interest in image-based high content screening are some of the prominent trends which drive the demand for high-end cellomics

The extensive research and development in drug discovery and are the chief driving factors.

The cumulative market share of the top players including PerkinElmer Inc. and Molecular Devices LLC (Danaher Corpoartion LLC) Corporation constitutes around 88.5% of the overall fragmented market.

U.S., China, India, Germany and UK are the top 5 countries that are driving the demand for

Europe will hold around 30% revenue share in the overall High-end Cellomics Market in 2021. Germany remains the fastest growing country in the Europe market, exhibiting a CAGR of 7.2% over the forecast period of 2021-2031.

The East Asia market is set to exhibit a CAGR of 6.9% during 2021-2031, the forecast period owing to the continuous research and development in the field of biotechnology which is driving the introduction of innovative and breakthrough technologies, thereby expanding the application areas of biotechnology tools in the region.

PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation are the key manufacturers.

Japan high-end cellomics market is expected to account for 10% of global sales through 2031. South Korea will account for 8% of total share through the end of the assessment period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Trends

    3.1. Key Trends Impacting the Market

    3.2. Trends in Diverse Application

4. Key Success Factors

    4.1. Key Products USP Analysis 

    4.2. Key Manufacturers Promotional Strategies

    4.3. Value Chain Analysis

    4.4. PESTLE Analysis

    4.5. PORTERS Analysis

    4.6. Key Regulations

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. GDP Growth Outlook

        5.1.2. Global Healthcare Industry Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Key Players Historic Growth 

        5.2.2. Extensive Research & Development Activities 

        5.2.3. New Product Launches & Approvals

        5.2.4. Growing Funding for Biotechnology/Life Science Sector 

        5.2.5. Rise in uptake of advanced High-end Cellomics Market 

        5.2.6. Growing R&D activities by Key Players

        5.2.7. Product Adoption

        5.2.8. Key Strategic Developments

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. COVID19 and Impact Analysis

    6.4. 2020 Market Scenario

    6.5. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global High-end Cellomics Market - Pricing Analysis

    7.1. Country Pricing Analysis by Product Type

    7.2. Global Average Pricing Analysis Benchmark

8. Global High-end Cellomics Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031

    8.1. Historical Market Volume (Units) Analysis, 2016-2020

    8.2. Current and Future Market Volume (Units) Projections, 2021-2031

        8.2.1. Y-o-Y Growth Trend Analysis

9. Global High-end Cellomics Market Value Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Application, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031

        10.3.1.  Academic Research/Basic Research

        10.3.2.  Drug Discovery

            10.3.2.1. Primary & Secondary Screening 

            10.3.2.2. Target Validation & Identification

            10.3.2.3. Toxicity Studies 

            10.3.2.4. Compound Profiling 

    10.4. Market Attractiveness Analysis by Application

11. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by End User, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2021-2031

        11.3.1. Pharmaceutical & Biotechnology Companies

        11.3.2. Academic Research Institutes 

        11.3.3. Independent Contract Research Organizations (CROs)

    11.4. Market Attractiveness Analysis by End User 

12. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Application

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

        14.3.2. By Application

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Application

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Singapore

            16.3.1.3. Thailand

            16.3.1.4. Indonesia

            16.3.1.5. Malaysia

        16.3.2. By Application

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

            17.3.1.4. Rest of East Asia

        17.3.2. By Application

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Application

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        19.3.1.  By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Rest of Middle East and Africa

        19.3.2. By Application

        19.3.3. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries High-end Cellomics Market Analysis 2021 & 2031

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. High-end Cellomics Market Analysis

        20.2.1. By Application

        20.2.2. By End User

    20.3. Canada High-end Cellomics Market Analysis

        20.3.1. By Application

        20.3.2. By End User

    20.4. Brazil High-end Cellomics Market Analysis

        20.4.1. By Application

        20.4.2. By End User

    20.5. Mexico High-end Cellomics Market Analysis

        20.5.1. By Application

        20.5.2. By End User

    20.6. U.K. High-end Cellomics Market Analysis

        20.6.1. By Application

        20.6.2. By End User

    20.7. Germany High-end Cellomics Market Analysis

        20.7.1. By Application

        20.7.2. By End User

    20.8. France High-end Cellomics Market Analysis

        20.8.1. By Application

        20.8.2. By End User

    20.9. Italy High-end Cellomics Market Analysis

        20.9.1. By Application

        20.9.2. By End User

    20.10. Spain High-end Cellomics Market Analysis

        20.10.1. By Application

        20.10.2. By End User

    20.11. BENELUX High-end Cellomics Market Analysis

        20.11.1. By Application

        20.11.2. By End User

    20.12. Russia High-end Cellomics Market Analysis

        20.12.1. By Application

        20.12.2. By End User

    20.13. China High-end Cellomics Market Analysis

        20.13.1. By Application

        20.13.2. By End User

    20.14. Japan High-end Cellomics Market Analysis

        20.14.1. By Application

        20.14.2. By End User

    20.15. South Korea High-end Cellomics Market Analysis

        20.15.1. By Application

        20.15.2. By End User

    20.16. India High-end Cellomics Market Analysis

        20.16.1. By Application

        20.16.2. By End User

    20.17. Singapore High-end Cellomics Market Analysis

        20.17.1. By Application

        20.17.2. By End User

    20.18. Thailand High-end Cellomics Market Analysis

        20.18.1. By Application

        20.18.2. By End User

    20.19. Malaysia High-end Cellomics Market Analysis

        20.19.1. By Application

        20.19.2. By End User

    20.20. Indonesia High-end Cellomics Market Analysis

        20.20.1. By Application

        20.20.2. By End User

    20.21. Australia High-end Cellomics Market Analysis

        20.21.1. By Application

        20.21.2. By End User

    20.22. New Zealand High-end Cellomics Market Analysis

        20.22.1. By Application

        20.22.2. By End User

    20.23. GCC Countries High-end Cellomics Market Analysis

        20.23.1. By Application

        20.23.2. By End User

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Market Share Analysis of Top Players 

    21.4. Brand Share Analysis, By Key Brands

    21.5. Competition Deep Dive 

        21.5.1. PerkinElmer, Inc.

                21.5.1.1.1. Overview

                21.5.1.1.2. Product Portfolio

                21.5.1.1.3. Analyst Commentary 

                21.5.1.1.4. Key Financials

            21.5.1.2. Recent Developments

            21.5.1.3. Sales Footprint

            21.5.1.4. Strategy Overview

                    21.5.1.4.1.1. Marketing Strategy

                    21.5.1.4.1.2. Product Strategy

                    21.5.1.4.1.3. Channel Strategy

        21.5.2. Molecular Devices LLC (Danaher Corporation)

                21.5.2.1.1. Overview

                21.5.2.1.2. Product Portfolio

                21.5.2.1.3. Analyst Commentary 

                21.5.2.1.4. Key Financials

            21.5.2.2. Recent Developments

            21.5.2.3. Sales Footprint

            21.5.2.4. Strategy Overview

                    21.5.2.4.1.1. Marketing Strategy

                    21.5.2.4.1.2. Product Strategy

                    21.5.2.4.1.3. Channel Strategy

        21.5.3. ThermoFisher Scientific 

                21.5.3.1.1. Overview

                21.5.3.1.2. Product Portfolio

                21.5.3.1.3. Analyst Commentary 

                21.5.3.1.4. Key Financials

            21.5.3.2. Recent Developments

            21.5.3.3. Sales Footprint

            21.5.3.4. Strategy Overview

                    21.5.3.4.1.1. Marketing Strategy

                    21.5.3.4.1.2. Product Strategy

                    21.5.3.4.1.3. Channel Strategy

        21.5.4. Yokogawa Electric Corporation

                21.5.4.1.1. Overview

                21.5.4.1.2. Product Portfolio

                21.5.4.1.3. Analyst Commentary 

                21.5.4.1.4. Key Financials

            21.5.4.2. Recent Developments

            21.5.4.3. Sales Footprint

            21.5.4.4. Strategy Overview

                    21.5.4.4.1.1. Marketing Strategy

                    21.5.4.4.1.2. Product Strategy

                    21.5.4.4.1.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global High-end Cellomics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 02: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 03: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 04: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 05: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 06: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 07: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 08: Latin America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 09: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 10: Latin America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 11: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 12: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 13: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 14: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 15: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 16: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 17: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 18: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 19: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 20: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 21: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 22: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 23: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 24: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 25: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global High-end Cellomics Market Revenue Share by Application, 2021E & 2031F

Figure 02: Global High-end High Content Screening System Market Revenue Share by End User, 2021E & 2031F

Figure 03: Global Average Pricing Analysis Benchmark USD (Unit) (2020)

Figure 04: Global High-end Cellomics Market Historical Market Volume (Units) Analysis, 2016-2020

Figure 05: Global High-end Cellomics Market Volume (Units), 2021-2031 & Y-o-Y Growth Trend Analysis

Figure 06: Global High-end Cellomics Market Historical Market Value (US$ Mn) Analysis, 2016-2020

Figure 07: Global High-end Cellomics Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis

Figure 08: Global High-end Cellomics Market Absolute $ Opportunity, 2021–2031

Figure 09: Global High-end Cellomics Market Share Analysis (%) By Application, 2021 & 2031

Figure 10: Global High-end Cellomics Market Y-o-Y Growth (%) By Application, 2021-2031

Figure 11: Global High-end Cellomics Market Attractiveness Analysis, By Applications

Figure 12: Global High-end Cellomics Market Share Analysis (%) By End User, 2021 & 2031

Figure 13: Global High-end Cellomics Market Y-o-Y Growth (%) By End User, 2021-2031

Figure 14: Global High-end Cellomics Market Attractiveness Analysis, By End User

Figure 15: Global High-end Cellomics Market Share Analysis (%) By Region, 2021 & 2031

Figure 16: Global High-end Cellomics Market Y-o-Y Growth (%) By Region, 2021-2031

Figure 17: Global High-end Cellomics Market Attractiveness Analysis, By Region

Figure 18: North America High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 19: North America High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 20: North America High-end Cellomics Market Share, By Application (2021)

Figure 21: North America High-end Cellomics Market Share, By End User (2021)

Figure 22: North America High-end Cellomics Market Share, By Region (2021)

Figure 23: North America High-end Cellomics Market Attractiveness Analysis, By Application

Figure 24: North America High-end Cellomics Market Attractiveness Analysis, By End User

Figure 25: North America High-end Cellomics Market Attractiveness Analysis, By Country

Figure 26: Latin America High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 27: Latin America High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 28: Latin America High-end Cellomics Market Share, By Application (2021

Figure 29: Latin America High-end Cellomics Market Share, By End User (2021)

Figure 30: Latin America High-end Cellomics Market Share, By Region (2021)

Figure 31: Latin America High-end Cellomics Market Attractiveness Analysis, By Application

Figure 32: Latin America High-end Cellomics Market Attractiveness Analysis, By End User

Figure 33: Latin America High-end Cellomics Market Attractiveness Analysis, By Country

Figure 34: Europe High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 35: Europe High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 36: Europe High-end Cellomics Market Share, By Application (2021)

Figure 37: Europe High-end Cellomics Market Share, By End User (2021)

Figure 38: Europe High-end Cellomics Market Share, By Region (2021

Figure 39: Europe High-end Cellomics Market Attractiveness Analysis, By Application

Figure 40: Europe High-end Cellomics Market Attractiveness Analysis, By End User

Figure 41: Europe High-end Cellomics Market Attractiveness Analysis, By Country

Figure 42: South Asia High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 43: South Asia High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 44: South Asia High-end Cellomics Market Share, By Application (2021)

Figure 45: South Asia High-end Cellomics Market Share, By End User (2021)

Figure 46: South Asia High-end Cellomics Market Share, By Region (2021)

Figure 47: South Asia High-end Cellomics Market Attractiveness Analysis, By Application

Figure 48: South Asia High-end Cellomics Market Attractiveness Analysis, By End User

Figure 49: South Asia High-end Cellomics Market Attractiveness Analysis, By Country

Figure 50: East Asia High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 51: East Asia High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 52: East Asia High-end Cellomics Market Share, By Application (2021)

Figure 53: East Asia High-end Cellomics Market Share, By End User (2021)

Figure 54: East Asia High-end Cellomics Market Share, By Region (2021)

Figure 55: East Asia High-end Cellomics Market Attractiveness Analysis, By Application

Figure 56: East Asia High-end Cellomics Market Attractiveness Analysis, By End User

Figure 57: East Asia High-end Cellomics Market Attractiveness Analysis, By Country

Figure 58: Oceania High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 59: Oceania High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 60: Oceania High-end Cellomics Market Share, By Application (2021)

Figure 61: Oceania High-end Cellomics Market Share, By End User (2021)

Figure 62: Oceania High-end Cellomics Market Share, By Region (2021)

Figure 63: Oceania High-end Cellomics Market Attractiveness Analysis, By Application

Figure 64: Oceania High-end Cellomics Market Attractiveness Analysis, By End User

Figure 65: Oceania High-end Cellomics Market Attractiveness Analysis, By Country

Figure 66: MEA High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020

Figure 67: MEA High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 68: MEA High-end Cellomics Market Share, By Application (2021)

Figure 69: MEA High-end Cellomics Market Share, By End User (2021)

Figure 70: MEA High-end Cellomics Market Share, By Region (2021)

Figure 71: MEA High-end Cellomics Market Attractiveness Analysis, By Application

Figure 72: MEA High-end Cellomics Market Attractiveness Analysis, By End User

Figure 73: MEA High-end Cellomics Market Attractiveness Analysis, By Country

Figure 74:  Global Vs. U.S. Growth Comparison

Figure 75: U.S. High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 76: U.S. High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 77:  Global Vs. Canada Growth Comparison

Figure 78: Canada High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 79: Canada High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 80:  Global Vs. Brazil Growth Comparison

Figure 81: Brazil High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 82: Brazil High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 83:  Global Vs. Mexico Growth Comparison

Figure 84: Mexico High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 85: Mexico High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 86: Global Vs. U.K. Growth Comparison

Figure 87: U.K. High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 88: U.K. High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 89:  Global Vs. Germany Growth Comparison

Figure 90: Germany High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 91: Germany High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 92:  Global Vs. Italy Growth Comparison

Figure 93: Italy High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 94: Italy High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 95:  Global Vs. France Growth Comparison

Figure 96: France High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 97: France High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 98:  Global Vs. Spain Growth Comparison

Figure 99: Spain High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 100: Spain High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 101: Global Vs. BENELUX Growth Comparison

Figure 102: BENELUX High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 103: BENELUX High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 104:  Global Vs. Russia Growth Comparison

Figure 105: Russia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 106: Russia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 107:  Global Vs. India Growth Comparison

Figure 108: India High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 109: India High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 110:  Global Vs. Singapore Growth Comparison

Figure 111: Singapore High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 112: Singapore High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 113:  Global Vs. Thailand Growth Comparison

Figure 114: Thailand High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 115: Thailand High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 116:  Global Vs. Malaysia Growth Comparison

Figure 117: Malaysia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 118: Malaysia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 119:  Global Vs. China Growth Comparison

Figure 120: China High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 121: China High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 122:  Global Vs. Japan Growth Comparison

Figure 123: Japan High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 124: Japan High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 125: Global Vs. South Korea Growth Comparison

Figure 126: South Korea High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 127: South Korea High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 128: Global Vs. Australia Growth Comparison

Figure 129: Australia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 130: Australia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 131: Global Vs. New Zealand Growth Comparison

Figure 132: New Zealand High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 133: New Zealand High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Figure 134:  Global Vs. GCC Countries Growth Comparison

Figure 135: GCC Countries High-end Cellomics Market Analysis (%) By Application, 2021 & 2031

Figure 136: GCC Countries High-end Cellomics Market Analysis (%) By End User, 2021 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Drainage Catheter Market

Published : April 2019

Healthcare

Organoids Market

Published : April 2021

Healthcare

Flow Cytometry Market

Published : October 2017

Healthcare

High Content Screening Market

Published : April 2021

Google translate

High-end Cellomics Market